Helix Energy Solutions Group, Inc. (HLX) Touches $8.33 Formed H&S; Atrion (ATRI) Sellers Decreased By 17.51% Their Shorts

Helix Energy Solutions Group, Inc. (NYSE:HLX) Logo

Atrion Corporation (NASDAQ:ATRI) had a decrease of 17.51% in short interest. ATRI’s SI was 17,900 shares in June as released by FINRA. Its down 17.51% from 21,700 shares previously. With 11,000 avg volume, 2 days are for Atrion Corporation (NASDAQ:ATRI)’s short sellers to cover ATRI’s short positions. The SI to Atrion Corporation’s float is 1.26%. The stock increased 0.05% or $0.3 during the last trading session, reaching $599.4. About 7,664 shares traded. Atrion Corporation (NASDAQ:ATRI) has risen 8.09% since June 30, 2017 and is uptrending. It has underperformed by 4.48% the S&P500. Some Historical ATRI News: 22/05/2018 – Atrion Corporation Declares Quarterly Cash Dividend; 09/05/2018 – ATRION 1Q EPS $4.57; 09/05/2018 – Atrion 1Q Rev $39.4M; 19/04/2018 – DJ Atrion Corporation, Inst Holders, 1Q 2018 (ATRI); 09/05/2018 – ATRION 1Q REV. $39.4M; 03/04/2018 – Investor Expectations to Drive Momentum within Atrion, Curis, Independence Contract Drilling, Utah Medical Products, FutureFuel; 19/03/2018 ATRION BOARD CHANGE VOTING STANDARD FOR ELECTING DIRECTORS

Helix Energy Solutions Group, Inc. (HLX) formed inverse H&S with $8.83 target or 6.00% above today’s $8.33 share price. Helix Energy Solutions Group, Inc. (HLX) has $1.23B valuation. The stock decreased 1.42% or $0.12 during the last trading session, reaching $8.33. About 5.09 million shares traded or 229.73% up from the average. Helix Energy Solutions Group, Inc. (NYSE:HLX) has risen 44.08% since June 30, 2017 and is uptrending. It has outperformed by 31.51% the S&P500. Some Historical HLX News: 23/04/2018 – HELIX ENERGY SOLUTIONS GROUP INC – QTRLY REVENUES $164.3 MLN VS $104.5 MLN; 30/04/2018 – Helix Energy Presenting at Morgan Stanley Conference May 7; 23/04/2018 – HELIX ENERGY 1Q REV. $164.3M, EST. $144.1M; 23/04/2018 – HELIX ENERGY SEES 2018 REV ABOUT $695M-$740M, SAW $685M-$730M; 23/04/2018 – Helix Energy Solutions 1Q Loss/Shr 2c; 27/04/2018 – Helix Energy at Morgan Stanley Energy Conference May 7; 23/04/2018 – Helix Energy Solutions 1Q Rev $164.3M; 18/04/2018 – Helix Energy Closes Above 50-Day Moving Average: Technicals; 14/05/2018 – Helix Energy Presenting at Conference Tomorrow; 25/04/2018 – HELIX ENERGY SOLUTIONS GROUP INC HLX.N : SIMMONS RAISES TARGET PRICE TO $9 FROM $7.10

Investors sentiment decreased to 1.3 in 2018 Q1. Its down 0.49, from 1.79 in 2017Q4. It dropped, as 2 investors sold Atrion Corporation shares while 42 reduced holdings. 21 funds opened positions while 36 raised stakes. 1.07 million shares or 0.64% less from 1.08 million shares in 2017Q4 were reported. Northern Tru accumulated 21,743 shares. Metropolitan Life Ins New York reported 0% of its portfolio in Atrion Corporation (NASDAQ:ATRI). Jpmorgan Chase And, New York-based fund reported 3,848 shares. D E Shaw & Com has 471 shares for 0% of their portfolio. Leavell Mgmt accumulated 778 shares or 0.06% of the stock. The California-based First Quadrant Lp Ca has invested 0.01% in Atrion Corporation (NASDAQ:ATRI). Bancorp Of Montreal Can has invested 0% in Atrion Corporation (NASDAQ:ATRI). Stifel Corporation holds 0% in Atrion Corporation (NASDAQ:ATRI) or 1,038 shares. 163 were accumulated by Great West Life Assurance Can. Spark Invest Management Ltd Liability holds 999 shares. 11,881 were reported by Proshare Advisors Limited. Price T Rowe Assoc Md holds 0.02% or 229,081 shares in its portfolio. Chevy Chase Trust Inc invested 0% of its portfolio in Atrion Corporation (NASDAQ:ATRI). Tower Capital Ltd Liability Company (Trc) invested in 0% or 29 shares. Aldebaran owns 1,400 shares.

Atrion Corporation develops, manufactures, and sells fluid delivery devices, and ophthalmic and cardiovascular products worldwide. The company has market cap of $1.11 billion. The companyÂ’s fluid delivery products include valves that promote infection control and needle safety, as well as for use in intubation, intravenous, catheter, and other applications in the fields of anesthesia and oncology. It has a 31.68 P/E ratio. The Company’s cardiovascular products comprise MPS2 myocardial protection system that delivers fluids and medications, and mixes drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products that are used in heart bypass surgery.

Helix Energy Solutions Group, Inc. (NYSE:HLX) Institutional Positions Chart